ABOUT US
NEWS
SERVICES
PRODUCTS
CONTACT US
CHINESE
ABOUT US
NEWS
SERVICES
PRODUCTS
CONTACT US

Science Significance Solution
Grounded in Science, Delivering Exceptional Strategies for Treating Disease at Its Source.

MORE

Science Significance Solution
Grounded in Science, Delivering Exceptional Strategies for Treating Disease at Its Source.

MORE

ABOUT US

關於我們

Grounded in Science, Driven by Significance, Providing Solutions. Our commitment lies in the development of therapeutic antibodies and macromolecular drugs, addressing unmet medical needs for the betterment of society.

MORE

LATEST NEWS

最新消息

2022 07/31
MORE
LectinStars Pharmaceuticals join 2022 BIO Asia- Taiwan
LectinStars Pharmaceuticals joins the 2022 BIO Asia- Taiwan on July 28-31 at booth R202.
2022 04/29
MORE
LectinStars Pharmaceuticals won the third place in the Innovation Challenge of 2022 NBRP DEMO DAY.
LectinStars Pharmaceuticals's core research product "SP-2021A (Anti-Siglec-3 (CD33) antibody for healing Chronic Hepatitis B) won the third prize in the Innovation Challenge of 2022 NBRP DEMO DAY.
MORE

TECHINICAL SERVICES

技術服務

SP-2021A
SP-2021A is a human anti-CD33 monoclonal antibody developed by LectinStars Pharmaceuticals Ltd. Pre-clinical experiments have confirmed its ability to activate immune cells in patients with chronic Hepatitis B, prompting the production of antibodies to combat HBsAg. This antibody represents a therapeutic breakthrough with the goal of achieving a cure for chronic Hepatitis B.
MORE
MORE

RECRUITING

人才招募

MORE